We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+14.19%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$117B
AUM Growth
+$9.87B
Cap. Flow
-$1.11B
Cap. Flow %
-0.95%
Top 10 Hldgs %
30.52%
Holding
4,391
New
216
Increased
2,182
Reduced
1,537
Closed
202

Top Buys

Rank Stock Value
1
COF icon
Capital One
COF
+$89.2M
2
FLUT icon
Flutter Entertainment
FLUT
+$43.9M
3
OKTA icon
Okta
OKTA
+$32.1M
4
CHWY icon
Chewy
CHWY
+$31.8M
5
COIN icon
Coinbase
COIN
+$26.9M

Sector Composition

Rank Sector Weight
1 Technology 31.83%
2 Financials 13.86%
3 Consumer Discretionary 10.91%
4 Healthcare 9.41%
5 Industrials 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPCE icon
3776
Virgin Galactic
SPCE
$498M
-40,487
Closed -$123K
STKS icon
3777
The ONE Group
STKS
$56.5M
-30,344
Closed -$90.7K
STRO icon
3778
Sutro Biopharma
STRO
$415M
-12,282
Closed -$79.9K
STTK icon
3779
Shattuck Labs
STTK
$686M
-51,053
Closed -$48.5K
TAYD icon
3780
Taylor Devices
TAYD
$172M
-2,357
Closed -$76.1K
TBLA icon
3781
Taboola.com
TBLA
$1.11B
-2,138
Closed -$6.31K
TCRX icon
3782
TScan Therapeutics
TCRX
$50.8M
-50,019
Closed -$69K
TGB
3783
Trekor Metals
TGB
$3.23B
-39
Closed -$87
TNYA icon
3784
Tenaya Therapeutics
TNYA
$168M
-69,193
Closed -$39.4K
TPIC
3785
DELISTED
TPI Composites
TPIC
-70,074
Closed -$56.5K
TSVT
3786
DELISTED
2seventy bio
TSVT
-84,817
Closed -$419K
TSQ icon
3787
Townsquare Media
TSQ
$100M
-18,036
Closed -$147K
UHG
3788
DELISTED
United Homes Group
UHG
-7,502
Closed -$21K
URG
3789
Ur-Energy
URG
$552M
-552,181
Closed -$372K
VERU icon
3790
Veru
VERU
$44.8M
-14,595
Closed -$71.5K
VRCA icon
3791
Verrica Pharmaceuticals
VRCA
$89.7M
-3,494
Closed -$15.4K
VTSI icon
3792
VirTra
VTSI
$35.6M
-8,811
Closed -$35.9K
VTYX
3793
DELISTED
Ventyx Biosciences
VTYX
-85,928
Closed -$98.8K
X
3794
DELISTED
US Steel
X
-622,304
Closed -$26.3M
XFOR icon
3795
X4 Pharmaceuticals
XFOR
$424M
-6,281
Closed -$44.5K
XIN
3796
DELISTED
Xinyuan Real Estate
XIN
-470
Closed -$1.21K
ZDGE icon
3797
Zedge
ZDGE
$38.8M
-1,911
Closed -$4.45K
ZNTL icon
3798
Zentalis Pharmaceuticals
ZNTL
$295M
-84,542
Closed -$134K
ZURA icon
3799
Zura Bio
ZURA
$528M
-36,577
Closed -$47.2K
ZYXI
3800
DELISTED
Zynex
ZYXI
-23,382
Closed -$51.4K

Similar funds

RhumbLine Advisers's Q2 2025 Portfolio in Review

As of Q2 2025, RhumbLine Advisers held 4,391 positions worth $117B, up 9.2% from $107B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

RhumbLine Advisers's Q2 2025 filing shows 216 new, 2,182 increased, 1,537 reduced and 202 closed positions. Its largest new stake was Ralliant Corp: 320,982 shares worth $15.6M. The largest sale was Discover Financial Services, an estimated $91M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Financials and Consumer Discretionary.

  • RhumbLine Advisers's largest Q2 2025 buy was Ralliant Corp: 320,982 shares worth $15.6M.
  • RhumbLine Advisers added most to Capital One in Q2 2025, an estimated $89.2M increase.
  • RhumbLine Advisers's biggest Q2 2025 reduction was iShares Russell 2000 ETF, cutting an estimated $75.5M.
  • RhumbLine Advisers fully exited Discover Financial Services in Q2 2025, selling an estimated $91M.
  • RhumbLine Advisers's ten largest holdings make up 31% of its $117B portfolio in Q2 2025.
  • RhumbLine Advisers opened 216 new positions and closed 202 in Q2 2025.
  • RhumbLine Advisers's portfolio value rose 9.2% quarter-over-quarter to $117B.

Based on RhumbLine Advisers's 13F filing for Q2 2025, filed 12 Aug 2025.